Search research articles

ABOUT JoVE

Overview Leadership Blog JoVE Help Center

AUTHORS

Publishing Process Editorial Board Scope & Policies Peer Review FAQ Submit

LIBRARIANS

Testimonials Subscriptions Access Resources Library Advisory Board FAQ

RESEARCH

JoVE Journal Methods Collections JoVE Encyclopedia of Experiments Archive

EDUCATION

JoVE Core JoVE Business JoVE Science Education JoVE Lab Manual Faculty Resource Center Faculty Site

Terms & Conditions of Use

Yanfei Han

2PUBLICATIONS

13CO-AUTHORS

Applied immunology (incl. antibody engineering, xenotransplantation and t-cell therapies)Radiation therapy

Featured researcher

Get your video featured.

Publish with JoVE

Featured researcher

Get your video featured.

Publish with JoVE

Publications (2)

Sort by Publication Date:

|Jan 07, 2022

A tumor-specific pro-IL-12 activates preexisting cytotoxic T cells to control established tumors.

Diyuan Xue, Benjamin Moon, Jing Liao

|May 08, 2021

The AIM2 and NLRP3 inflammasomes trigger IL-1-mediated antitumor effects during radiation.

Chuanhui Han, Victoria Godfrey, Zhida Liu

Pageof 1

Frequent Collaborators

2 joint publications

Hua Peng

1 joint publications

Chuanhui Han

1 joint publications

Victoria Godfrey

1 joint publications

Zhida Liu

1 joint publications

Longchao Liu

1 joint publications

Ralph R Weichselbaum

1 joint publications

Hasan Zaki

1 joint publications

Yang-Xin Fu

1 joint publications

Diyuan Xue

1 joint publications

Benjamin Moon

Frequent Collaborators

2 joint publications

Hua Peng

1 joint publications

Chuanhui Han

1 joint publications

Victoria Godfrey

1 joint publications

Zhida Liu

Top Related Videos

<em>Ex vivo</em> Expansion of Tumor-reactive T Cells by Means of Bryostatin 1/Ionomycin and the Common Gamma Chain Cytokines Formulation

<em>Ex vivo</em> Expansion of Tumor-reactive T Cells by Means of Bryostatin 1/Ionomycin and the Common Gamma Chain Cytokines Formulation

Published on : Jan 14, 2011

Evaluation of the <em>In vivo</em> Antitumor Activity of Polyanhydride IL-1α Nanoparticles

Evaluation of the <em>In vivo</em> Antitumor Activity of Polyanhydride IL-1α Nanoparticles

Published on : Jun 28, 2021

See more related videos

Top Related Videos

<em>Ex vivo</em> Expansion of Tumor-reactive T Cells by Means of Bryostatin 1/Ionomycin and the Common Gamma Chain Cytokines Formulation

<em>Ex vivo</em> Expansion of Tumor-reactive T Cells by Means of Bryostatin 1/Ionomycin and the Common Gamma Chain Cytokines Formulation

Published on : Jan 14, 2011

Evaluation of the <em>In vivo</em> Antitumor Activity of Polyanhydride IL-1α Nanoparticles

Evaluation of the <em>In vivo</em> Antitumor Activity of Polyanhydride IL-1α Nanoparticles

Published on : Jun 28, 2021

See more related videos